Four-Race Agreement with GSK
GSK will be on both the No. 11 Toyota Camry TRD and No. 20 Toyota Camry TRD
Joe Gibbs Racing (JGR) announces an agreement with GSK (GlaxoSmithKline) to feature SHINGRIX® (Zoster Vaccine Recombinant, Adjuvanted), over four races beginning in March.
GSK’s SHINGRIX will be featured on Denny Hamlin’s No. 11 Toyota Camry TRD at Phoenix Raceway (March 12), Atlanta Motor Speedway (March 19), and Richmond Raceway (April 2). In addition, SHINGRIX will be featured on the No. 20 Toyota Camry TRD with driver Christopher Bell at Martinsville Speedway (April 16).
“We are excited to announce our agreement with GSK to feature SHINGRIX,” said Joe Gibbs, owner of Joe Gibbs Racing. GSK is one of the world’s leading research-based pharmaceutical and healthcare companies that prioritize innovation in vaccines and specialty medicines, maximizing the increasing opportunities to prevent and treat disease.
We’d like to thank GSK for their support of the #11 SHINGRIX Toyota Camry TRD, which will debut this weekend at Phoenix.
— Joe Gibbs Racing (@JoeGibbsRacing) March 7, 2023
Learn more at https://t.co/bGHNaC0cXf pic.twitter.com/pCF09yhIDL
source: Joe Gibbs Racing Media
No comments:
Post a Comment